These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15634880)

  • 21. IgA receptors in health and disease.
    Wines BD; Hogarth PM
    Tissue Antigens; 2006 Aug; 68(2):103-14. PubMed ID: 16866880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition.
    van der Boog PJ; van Kooten C; van Zandbergen G; Klar-Mohamad N; Oortwijn B; Bos NA; van Remoortere A; Hokke CH; de Fijter JW; Daha MR
    Nephrol Dial Transplant; 2004 Nov; 19(11):2729-36. PubMed ID: 15340093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils.
    Pleass RJ; Andrews PD; Kerr MA; Woof JM
    Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):771-7. PubMed ID: 8836118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pro-inflammatory role of Fcα/μR on marginal zone B cells in sepsis.
    Shibuya A; Honda SI; Shibuya K
    Int Immunol; 2017 Dec; 29(11):519-524. PubMed ID: 29281010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human IgA as a heterovalent ligand: switching from the asialoglycoprotein receptor to secretory component during transport across the rat hepatocyte.
    Schiff JM; Fisher MM; Jones AL; Underdown BJ
    J Cell Biol; 1986 Mar; 102(3):920-31. PubMed ID: 3949883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgA, IgA receptors, and their anti-inflammatory properties.
    Mkaddem SB; Christou I; Rossato E; Berthelot L; Lehuen A; Monteiro RC
    Curr Top Microbiol Immunol; 2014; 382():221-35. PubMed ID: 25116102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Existence and function of a receptor for immunoglobulin A on human eosinophils].
    Capron M; Tomassini M; Van der Vorst E; Kusnierz JP; Papin JP; Capron A
    C R Acad Sci III; 1988; 307(7):397-402. PubMed ID: 2847860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and functional characteristics of the Fcalpha/muR, a novel Fc receptor for IgM and IgA.
    Shibuya A; Honda S
    Springer Semin Immunopathol; 2006 Dec; 28(4):377-82. PubMed ID: 17061088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model.
    Koernig S; Campbell IK; Mackenzie-Kludas C; Schaub A; Loetscher M; Ching Ng W; Zehnder R; Pelczar P; Sanli I; Alhamdoosh M; Ng M; Brown LE; Käsermann F; Vonarburg C; Zuercher AW
    Mucosal Immunol; 2019 Jul; 12(4):1013-1024. PubMed ID: 31105268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and function of human IgA Fc receptors (Fc alpha R).
    Morton HC; van Egmond M; van de Winkel JG
    Crit Rev Immunol; 1996; 16(4):423-40. PubMed ID: 8954257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple transcripts of human IgA Fc receptor CD89 in neutrophils, eosinophils and the monocyte-like cell line THP-1.
    Pleass RJ; Dunlop JI; Woof JM
    Biochem Soc Trans; 1997 May; 25(2):327S. PubMed ID: 9191372
    [No Abstract]   [Full Text] [Related]  

  • 33. The Fc receptor for IgA (FcalphaRI, CD89).
    Otten MA; van Egmond M
    Immunol Lett; 2004 Mar; 92(1-2):23-31. PubMed ID: 15081523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals.
    Monteiro RC; Hostoffer RW; Cooper MD; Bonner JR; Gartland GL; Kubagawa H
    J Clin Invest; 1993 Oct; 92(4):1681-5. PubMed ID: 8408621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA.
    Cottignies-Calamarte A; Tudor D; Bomsel M
    Front Immunol; 2023; 14():1037033. PubMed ID: 36817447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD89: the human myeloid IgA Fc receptor.
    Morton HC; Brandtzaeg P
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):217-29. PubMed ID: 11478396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin A-mediated protection against Bordetella pertussis infection.
    Hellwig SM; van Spriel AB; Schellekens JF; Mooi FR; van de Winkel JG
    Infect Immun; 2001 Aug; 69(8):4846-50. PubMed ID: 11447159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria.
    Langley R; Wines B; Willoughby N; Basu I; Proft T; Fraser JD
    J Immunol; 2005 Mar; 174(5):2926-33. PubMed ID: 15728504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of IgA receptors in the pathogenesis of IgA nephropathy.
    Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
    J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mac-1 (CD11b/CD18) as accessory molecule for Fc alpha R (CD89) binding of IgA.
    Van Spriel AB; Leusen JH; Vilé H; Van De Winkel JG
    J Immunol; 2002 Oct; 169(7):3831-6. PubMed ID: 12244179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.